There is no cure as yet for HIV, which means that medicines to control the vius must be taken life-long. The regime is complicated, and particularly difficult for people challenged environmentally, culturally and physiologically with poverty, stigma and the process of ageing itself. The forthcoming CCS public lecture being given by Professor Jenny Hoy focuses on how long term infection with HIV and its treatment with antiretroviral therapy affects different body systems which contribute to the increased likelihood of chronic illness such as cardiovascular disease and osteoporosis. 10 July lecture details:Link RSVP: Link
Professorial Grand Round - Dr Donovan Moncur
Tue Jun 3
ACBD and Dept Med Seminar Series
Seminar: Social Media for
Thur Jun 5
BSc and Masters (Part 1) Research seminar
Fri Jun 6
MIDS: AIRmed/Infectious Diseases
Mon Jun 9
Professorial Grand Round
Tue Jun 10
Medicine/ACBD seminar series -
Mr Belden Mado
ACBD and Dept Med Seminar Series
Wed Jun 11
Lung Health Education Program
2014 - Respiratory Course
Clinical Pathology Review
Major CCS events
10 July 2014 CCS Public lecture "Challenges of living well with HIV: Where to from here?"
Professor Jenny Hoy
CCS is holding its annual public lecture for 2014 on 10 July, on a viral infection that has changed our world, the Human immunodeficiency virus infection (HIV). Professor Jennifer Hoy has 30 years' experience in HIV clinical research and patient care, particularly on how HIV contributes to the increased likelihood of chronic illness such as cardiovascular disease and osteoporosis. She will describe how the lives of people with HIV transform, how her current research is changing the way doctors help people with HIV, and outline the challenges ahead. See web page with detail & RSVP link.
The ANZCA Trials Group recently announced the much anticipated results of the ENIGMA-II trial. Professor Paul Myles, Director of Anaesthesia and Perioperative Medicine at Alfred Hospital and the Monash department of the same name within Central Clinical School, presented the results at the combined plenary session at the Australian and New Zealand College of Anaesthetist (ANZCA) ASM and Royal Australian College of Surgeons (RACS) ASC on May 6, 2014. Verdict: Nitrous oxide is safe.
The Bachelor of Medical Science (Honours) information night for 2015 intake was attended by between 50 and 60 students. Central Clinical School had representatives from MAPrc, CCS and Cabrini. A big 'Thank you!' to our two current BMedSc(Hons) student representatives, Stephen Surace and Treasa Gray (pictured, left) for an excellent job representing the school. See more:
Central Clinical School will be offering a suite of courses specialising in translational research and its management. The first two are now open for participants. See their respective links for eligibility criteria and detail of content.
26/05/2014 Dr Katie Flanagan, an adjunct senior lecturer in the Department of Immunology, commented that people
can be bombarded with information about vaccinations which can make it
hard for them to pick out the right information. ABC Radio
See more about Dr Flanagan and her work.
26/05/2014 Professor Peter Gibson, Department of Gastroenterology, has
released new research on the rates of experienced depression by people
who are gluten intolerant. Gibson said studies show that gluten seemed to specifically cause depression over a short time. Hobart Mercury, Herald Sun, Channel 9
27/05/2014 Radio National, Channel 9, WIN TV, Sky News
29/05/204Professor Gibson said that no specific response to gluten could be found, in contrast to their first study which suggested that gluten could trigger gastrointestinal pain in people without coeliac disease. NBR Food Industry week, New Zealand General News, page 6
29/05/2014 Professor Kulkarnicommented on new research which has revealed that oestrogen can help treat schizophrenia in previously treatment-resistant women.The study is the first large scale trial for women with treatment-resistant schizophrenia. MX
People with depression who are also overweight are more likely to have chronic symptoms. It may be that inflammation and high insulin levels associated with being overweight make depression worse. Metformin in a medication usually used for diabetes that lowers inflammation and insulin levels and has been shown to help with weight loss. TheMonash Alfred Psychiatry Research centreis investigating the effectiveness of metformin in combination with standard antidepressants at causing weight loss and improving depressive symptoms.This is a 12 week trial. Men and women aged 18-65 who have depression, are taking an antidepressant, and are overweight or have an increased waist circumference, are invited to participate. Study link:ccs-clin-trials.med.monash.edu.au/trials/metformin-weight-loss-and-depression